ビオフェルミン製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証1部 | 医薬品 | 4517/E00960 | BIOFERMIN PHARMACEUTICAL CO.,LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2021/05/07 | 日証協 | 20,500株 | -3.3% | 8,733株 | -73.4% | 35,013株 | -1.41% | 483株 | -76.81% |
| 2021/04/30 | 日証協 | 21,200株 | +4.95% | 32,832株 | +28.55% | 35,513株 | +1.72% | 2,083株 | -54.72% |
| 2021/04/23 | 日証協 | 20,200株 | +23.17% | 25,540株 | +9999.99% | 34,913株 | +1.16% | 4,600株 | +420.95% |
| 2021/04/16 | 日証協 | 16,400株 | -11.83% | 26株 | -87% | 34,513株 | -2.38% | 883株 | -44.81% |
| 2021/04/09 | 日証協 | 18,600株 | -61.57% | 200株 | -99.14% | 35,356株 | -47.57% | 1,600株 | -93.95% |
| 2021/04/02 | 日証協 | 48,400株 | +0.21% | 23,200株 | +152.17% | 67,437株 | +2.87% | 26,427株 | -26.59% |
| 2021/03/26 | 日証協 | 48,300株 | +13.11% | 9,200株 | +820% | 65,556株 | +83.34% | 36,000株 | +800% |
| 2021/03/19 | 日証協 | 42,700株 | -3.61% | 1,000株 | -95.55% | 35,756株 | -10.29% | 4,000株 | -42.03% |
| 2021/03/12 | 日証協 | 44,300株 | +0.68% | 22,468株 | +111.24% | 39,856株 | +2.56% | 6,900株 | +137.52% |
| 2021/03/05 | 日証協 | 44,000株 | +2.33% | 10,636株 | +62.73% | 38,861株 | +3.75% | 2,905株 | +11.73% |
| 2021/02/26 | 日証協 | 43,000株 | +0.47% | 6,536株 | -72.46% | 37,456株 | +2.45% | 2,600株 | -77.78% |
| 2021/02/19 | 日証協 | 42,800株 | +4.9% | 23,736株 | +465.14% | 36,560株 | +12.25% | 11,700株 | +290% |
| 2021/02/12 | 日証協 | 40,800株 | +3.55% | 4,200株 | -68.43% | 32,569株 | -2.54% | 3,000株 | -59.33% |
| 2021/02/05 | 日証協 | 39,400株 | +5.07% | 13,304株 | +204.58% | 33,419株 | -0.67% | 7,376株 | +63.91% |
| 2021/01/29 | 日証協 | 37,500株 | +3.02% | 4,368株 | +553.89% | 33,643株 | -1.61% | 4,500株 | -15.89% |
| 2021/01/22 | 日証協 | 36,400株 | +0.83% | 668株 | +234% | 34,193株 | -1.16% | 5,350株 | +409.52% |
| 2021/01/15 | 日証協 | 36,100株 | -0.82% | 200株 | -86.79% | 34,593株 | -2.12% | 1,050株 | -74.07% |
| 2021/01/08 | 日証協 | 36,400株 | 0% | 1,514株 | 0% | 35,343株 | +6.64% | 4,050株 | +1250% |
| 2020/12/30 | 日証協 | 36,400株 | -3.45% | 0株 | -100% | 33,143株 | -9.3% | 300株 | -94.18% |
※株式分割は考慮していませんのでご注意ください。